
Cuflik-AD Syrup
Marketer
Nuliek Healthcare
Salt Composition
Phenylephrine (5mg/5ml) + Chlorpheniramine Maleate (2mg/5ml) + Dextromethorphan Hydrobromide (10mg/5ml)
Overview Cuflik-AD Syrup
Respiflu-C Syrup is a medication employed to manage symptoms of the common cold and cough. It offers rapid alleviation of cold and cough symptoms such as nasal discharge, nasal congestion, sneezing, tearing eyes, and chest congestion. Respiflu-C Syrup should be administered as directed by a physician, with or without food. Dosage is tailored to individual needs and response. Complete the prescribed course; premature discontinuation may lead to symptom recurrence and worsening of your condition. Inform your healthcare provider of all other medications you are using, as interactions are possible. Potential side effects include headache, drowsiness, blurred vision, vomiting, diarrhea, dry mouth, and nausea. Most are transient and self-limiting. Report any concerning side effects immediately. This medication may induce sleepiness; avoid driving or activities requiring alertness until its effects are known. Alcohol consumption should be avoided due to the risk of increased drowsiness. Self-medication and recommending this medication to others are strongly discouraged. Adequate hydration is recommended during treatment. Prior to commencing treatment, inform your physician if you are pregnant, planning pregnancy, breastfeeding, or have liver or kidney disease to ensure appropriate dosage.
Uses of Cuflik-AD Syrup
Managing dry cough and the common cold
Major Benefits of Cuflik-AD Syrup:
Administer this medication precisely as your physician prescribes, adhering to both the dosage and treatment schedule. Always consult the product label for complete instructions prior to ingestion. Use a measuring device to ensure accurate dosing, and take orally. Thorough shaking is required before each use. Cuflik-AD Syrup can be consumed with or without food; however, consistent timing is recommended for optimal results.
Common Side effects of Cuflik-AD Syrup:
- Sedation
- Double vision
- Vomiting
- Diarrhea
- Dryness in mouth
- Nervousness
- Headache
- Nausea
- Decreased appetite
- Heartburn
- Dizziness
- Weakness
- Discomfort when urinating
- Polyuria
- Urinary retention
- Insomnia (difficulty in sleeping)
- Hallucination
- Convulsion
How to use Cuflik-AD Syrup:
Administer this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Consult the product label for detailed instructions prior to consumption. Accurate measurement should be achieved using a designated measuring cup; oral ingestion is the intended route of administration. Ensure thorough shaking before each use. Cuflik-AD Syrup can be ingested with or without food, although consistent daily timing is preferred.
How Cuflik-AD Syrup works:
Cuflik-AD Syrup blends three active ingredients: Phenylephrine, Chlorpheniramine Maleate, and Dextromethorphan Hydrobromide, to address common cold symptoms. Phenylephrine acts as a decongestant, constricting nasal blood vessels to alleviate stuffiness. Chlorpheniramine Maleate, an antihistamine, targets allergy-related symptoms such as sneezing, runny nose, and watery eyes. Finally, Dextromethorphan Hydrobromide functions as a cough suppressant, calming cough reflexes by affecting the brain's cough center.
SAFETY ADVICE
AlcoholCAUTION
Use of Cuflik-AD Syrup with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Cuflik-AD Syrup during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice before using this medication.
Breast feedingCONSULT YOUR DOCTOR
The use of Cuflik-AD Syrup while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by side effects associated with Cuflik-AD Syrup.
KidneySAFE IF PRESCRIBED
The use of Cuflik-AD Syrup in individuals with kidney impairment is likely safe. Preliminary findings indicate dose modification may be unnecessary, however, physician consultation is recommended.
LiverUNSAFE
Patients with liver impairment should likely refrain from using Cuflik-AD Syrup; medical advice is recommended.
What if you forget to take Cuflik-AD Syrup :
Should you forget a Cuflik-AD Syrup dose, administer it promptly. However, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Cuflik-AD Syrup
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Breathing |
